Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2009 Filed Jun 25, 2009 19:11 UTC |
CORDES EUGENEDirector
|
SaleCommon Stock | 2,000 | $31.16 | $62,320.00 |
DisclosureSEC source: 0000875320-09-000049 · edgar.xml · nonDerivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Read SEC document |
| June 10, 2009 Filed Jun 11, 2009 19:52 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000045 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,574 Underlying: Common Stock · 6,400 shares Expires 2009-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| June 10, 2009 Filed Jun 11, 2009 19:52 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 6,400 | $30.12 | $192,768.00 |
DisclosureSEC source: 0000875320-09-000045 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $30.12 (range $29.84 to $30.37). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| June 10, 2009 Filed Jun 11, 2009 19:52 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000045 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2009 Filed Jun 4, 2009 19:58 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000044 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,974 Underlying: Common Stock · 6,400 shares Expires 2009-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| June 03, 2009 Filed Jun 4, 2009 19:58 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 6,400 | $31.41 | $201,024.00 |
DisclosureSEC source: 0000875320-09-000044 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $31.41 (range $31.26 to $31.56). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| June 03, 2009 Filed Jun 4, 2009 19:58 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000044 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2009 Filed Jun 3, 2009 18:35 UTC |
SACHS BRUCE IDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.89 | $0.00 |
DisclosureSEC source: 0000875320-09-000037 · edgar.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2019-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2009 Filed Jun 3, 2009 18:36 UTC |
SANDERS CHARLES ADirector
|
GrantStock Option · Derivative | 40,000 | $0.00 Strike: $29.89 | $0.00 |
DisclosureSEC source: 0000875320-09-000038 · edgar.xml · derivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock · 40,000 shares Expires 2019-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2009 Filed Jun 3, 2009 18:38 UTC |
ULLIAN ELAINEDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.89 | $0.00 |
DisclosureSEC source: 0000875320-09-000039 · edgar.xml · derivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2019-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2009 Filed Jun 3, 2009 18:40 UTC |
CORDES EUGENEDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.89 | $0.00 |
DisclosureSEC source: 0000875320-09-000040 · edgar.xml · derivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2019-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fullly vested. Read SEC document |
| June 01, 2009 Filed Jun 3, 2009 18:43 UTC |
BOGER JOSHUA SDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.89 | $0.00 |
DisclosureSEC source: 0000875320-09-000041 · edgar.xml · derivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2019-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2009 Filed Jun 3, 2009 18:45 UTC |
BRIMBLECOMBE ROGER WDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.89 | $0.00 |
DisclosureSEC source: 0000875320-09-000042 · edgar.xml · derivative · entry 1 BRIMBLECOMBE ROGER W · CIK 0001197034 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2019-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2009 Filed Jun 3, 2009 18:47 UTC |
COLLINSON STUART JDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $29.89 | $0.00 |
DisclosureSEC source: 0000875320-09-000043 · edgar.xml · derivative · entry 1 COLLINSON STUART J · CIK 0001197037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2019-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| May 27, 2009 Filed May 28, 2009 20:15 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 26,900 | $29.44 | $791,936.00 |
DisclosureSEC source: 0000875320-09-000036 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $29.44 (range $29.09 to $29.89). Read SEC document |
| May 26, 2009 Filed May 28, 2009 20:15 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 24,800 | $29.49 | $731,352.00 |
DisclosureSEC source: 0000875320-09-000036 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093,295 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $29.49 (range $29.23 to $29.74). Read SEC document |
| May 26, 2009 Filed May 28, 2009 20:15 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,100 | $28.75 | $60,375.00 |
DisclosureSEC source: 0000875320-09-000036 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118,095 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.75 (range $28.17 to $29.16). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2009 Filed May 19, 2009 18:13 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionStock Option · Derivative | 3,333 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000875320-09-000029 · edgar.xml · derivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,333 shares Expires 2009-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| May 18, 2009 Filed May 19, 2009 18:13 UTC |
SANDERS CHARLES ADirector
|
SaleCommon Stock | 3,333 | $28.44 | $94,790.52 |
DisclosureSEC source: 0000875320-09-000029 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,383 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted averae price of $28.44 (range $28.11 to $28.93). F3 · price: Dr. Sanders undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2009 Filed May 19, 2009 18:13 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionCommon Stock | 3,333 | $10.05 | $33,496.65 |
DisclosureSEC source: 0000875320-09-000029 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2009 Filed May 19, 2009 18:15 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 925 | $28.44 | $26,307.00 |
DisclosureSEC source: 0000875320-09-000030 · edgar.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,035 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.44 (range $28.12 to $28.95). F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2009 Filed May 19, 2009 18:21 UTC |
GARRISON RICHARD CSVP and Catalyst
|
SaleCommon Stock | 532 | $28.45 | $15,135.40 |
DisclosureSEC source: 0000875320-09-000031 · edgar.xml · nonDerivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,473 F1 · kind: Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. F2 · kind: Open market sales reported on this line occurred at a weighted average price of $28.45 (range $28.12 to $28.95). F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.45 (range $28.12 to $28.95). F3 · price: Mr. Garrison undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2009 Filed May 19, 2009 18:24 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 925 | $28.44 | $26,307.00 |
DisclosureSEC source: 0000875320-09-000033 · edgar.xml · nonDerivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,248 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.44 (range $28.12 to $28.93). F3 · price: Mr. Graves undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2009 Filed May 19, 2009 18:25 UTC |
Sachdev AmitSVP, Corp Affairs & Pub Policy
|
SaleCommon Stock | 783 | $28.44 | $22,268.52 |
DisclosureSEC source: 0000875320-09-000034 · edgar.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,366 F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted average price of $28.44 (range $28.12 to $28.92). F3 · price: Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 18, 2009 Filed May 19, 2009 18:31 UTC |
Silva Paul MV.P. and Corporate Controller
|
SaleCommon Stock | 468 | $28.44 | $13,309.92 |
DisclosureSEC source: 0000875320-09-000035 · edgar.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · V.P. and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 15, 2009 Filed May 19, 2009 18:22 UTC |
MUELLER PETEREVP Global R&D, CSO
|
Exercise / conversionStock Option · Derivative | 2,400 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-09-000032 · edgar.xml · derivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 2,400 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| May 15, 2009 Filed May 19, 2009 18:22 UTC |
MUELLER PETEREVP Global R&D, CSO
|
SaleCommon Stock | 2,400 | $28.56 | $68,544.00 |
DisclosureSEC source: 0000875320-09-000032 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,874 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.56 (range $28.42 to $28.73). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2009 Filed May 19, 2009 18:22 UTC |
MUELLER PETEREVP Global R&D, CSO
|
Exercise / conversionCommon Stock | 2,400 | $9.69 | $23,256.00 |
DisclosureSEC source: 0000875320-09-000032 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2009 Filed May 12, 2009 18:03 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionStock Option · Derivative | 3,333 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000875320-09-000028 · edgar.xml · derivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Underlying: Common Stock · 3,333 shares Expires 2009-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| May 11, 2009 Filed May 12, 2009 18:03 UTC |
SANDERS CHARLES ADirector
|
SaleCommon Stock | 3,333 | $30.41 | $101,356.53 |
DisclosureSEC source: 0000875320-09-000028 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,383 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted averae price of $30.41 (range $29.99 to $30.63). F3 · price: Dr. Sanders undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2009 Filed May 12, 2009 18:03 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionCommon Stock | 3,333 | $10.05 | $33,496.65 |
DisclosureSEC source: 0000875320-09-000028 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2009 Filed May 11, 2009 18:50 UTC |
MUELLER PETEREVP, Global R&D, CSO
|
SaleCommon Stock | 12,796 | $28.94 | $370,316.24 |
DisclosureSEC source: 0000875320-09-000024 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,796 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan establishded under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.94 (range $28.71 to $29.20). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2009 Filed May 11, 2009 18:53 UTC |
BOGER KENNETH SSVP & General Counsel
|
SaleCommon Stock | 11,826 | $28.89 | $341,653.14 |
DisclosureSEC source: 0000875320-09-000025 · edgar.xml · nonDerivative · entry 1 BOGER KENNETH S · CIK 0001046336 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,857 F1 · kind: Transaction made pursuant to Mr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales repoted on this line occurred at a weighted average price of $28.89 (range $28.70 to $29.20). F3 · price: Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2009 Filed May 11, 2009 18:55 UTC |
BOGER JOSHUA SDirector · CEO
|
SaleCommon Stock | 22,050 | $28.95 | $638,347.50 |
DisclosureSEC source: 0000875320-09-000026 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120,195 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.95 (range $28.60 to $29.23). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 07, 2009 Filed May 11, 2009 18:57 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 32,500 | $28.90 | $939,250.00 |
DisclosureSEC source: 0000875320-09-000027 · edgar.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,035 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan establishd under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $28.90 (range $28.70 to $29.23). F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2009 Filed May 5, 2009 16:59 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionStock Option · Derivative | 3,334 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000875320-09-000023 · edgar.xml · derivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,666 Underlying: Common Stock · 3,334 shares Expires 2009-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| May 04, 2009 Filed May 5, 2009 16:59 UTC |
SANDERS CHARLES ADirector
|
SaleCommon Stock | 3,334 | $30.08 | $100,286.72 |
DisclosureSEC source: 0000875320-09-000023 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,383 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted averae price of $30.08 (range $29.85 to $30.50). F3 · price: Dr. Sanders undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2009 Filed May 5, 2009 16:59 UTC |
SANDERS CHARLES ADirector
|
Exercise / conversionCommon Stock | 3,334 | $10.05 | $33,506.70 |
DisclosureSEC source: 0000875320-09-000023 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2009 Filed Apr 29, 2009 20:00 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,507 | $32.00 | $80,224.00 |
DisclosureSEC source: 0000875320-09-000022 · edgar.xml · nonDerivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,248 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 21, 2009 Filed Apr 22, 2009 19:01 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 210 | $27.34 | $5,741.40 |
DisclosureSEC source: 0000875320-09-000021 · edgar.xml · nonDerivative · entry 2 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,755 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $27.34 (range $27.19 to $27.65). F4 · price: Mr. Graves undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| April 21, 2009 Filed Apr 22, 2009 19:01 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 283 | $26.72 | $7,561.76 |
DisclosureSEC source: 0000875320-09-000021 · edgar.xml · nonDerivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,965 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a wieghted average price of $26.72 (range $26.51 to ($26.97). F4 · price: Mr. Graves undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| April 15, 2009 Filed Apr 16, 2009 17:39 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionStock Option · Derivative | 2,400 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-09-000019 · edgar.xml · derivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Underlying: Common Stock · 2,400 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| April 15, 2009 Filed Apr 16, 2009 17:39 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 2,400 | $26.98 | $64,752.00 |
DisclosureSEC source: 0000875320-09-000019 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,670 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $26.98 (range $26.64 to $27.19). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| April 15, 2009 Filed Apr 16, 2009 17:39 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionCommon Stock | 2,400 | $9.69 | $23,256.00 |
DisclosureSEC source: 0000875320-09-000019 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2009 Filed Apr 16, 2009 17:41 UTC |
SACHS BRUCE IDirector
|
Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0000875320-09-000020 · edgar.xml · derivative · entry 3 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2009-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| April 15, 2009 Filed Apr 16, 2009 17:41 UTC |
SACHS BRUCE IDirector
|
SaleCommon Stock | 10,000 | $26.98 | $269,800.00 |
DisclosureSEC source: 0000875320-09-000020 · edgar.xml · nonDerivative · entry 2 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,710 F1 · kind: Transaction made pursuant to Mr. Sach's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $26.98 (range $26.63 to $27.19). F3 · price: Mr. Sach's undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| April 15, 2009 Filed Apr 16, 2009 17:41 UTC |
SACHS BRUCE IDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.05 | $100,500.00 |
DisclosureSEC source: 0000875320-09-000020 · edgar.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2009 Filed Mar 20, 2009 18:12 UTC |
Lewis-Hall Freda CEVP, Medicines Development
|
SaleCommon Stock | 1,250 | $29.11 | $36,387.50 |
DisclosureSEC source: 0000875320-09-000018 · edgar.xml · nonDerivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · EVP, Medicines Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,334 F1 · kind: Transaction made pursuant to Dr. Lewis-Hall's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $29.11 (range $28.85 to $29.78). F3 · price: Dr. Lewis-Hall undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| March 16, 2009 Filed Mar 17, 2009 17:24 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionStock Option · Derivative | 2,400 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-09-000017 · edgar.xml · derivative · entry 5 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Underlying: Common Stock · 2,400 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| March 16, 2009 Filed Mar 17, 2009 17:24 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 1,000 | $28.98 | $28,980.00 |
DisclosureSEC source: 0000875320-09-000017 · edgar.xml · nonDerivative · entry 3 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,356 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $28.98 (range $28.76 to $29.13). F4 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.